INTRODUCTION
Black Americans have higher age-adjusted blood pressure (BP) than White Americans, 1 yet the causes of this disparity remain uncertain. Previous studies have suggested that diet, obesity, social support, and stress may contribute, but these factors do not seem to fully explain higher Black BP. [2] [3] [4] Vitamin D is critical to bone health, but ubiquitous vitamin D receptors and effects on myriads of genes suggest broader clinical effects. 5 Genetic knockout models suggest vascular effects of vitamin D, including vascular endothelium, the renin-angiotensin axis, 6 and vascular smooth muscle including cell proliferation, 7 inflammation, 6 thrombosis, 8 cardiac hypertrophy, 9 and hyperparathyroid hormone secretion. 10 Prospective cohort data suggest low serum vitamin D levels might contribute to cardiovascular disease, 11 in part through elevated BP. 12 Serum vitamin D levels are largely driven by ultraviolet (UV) synthesis in the skin. 11 Darker skin impedes UV penetration and reduces vitamin D production; this relationship is particularly critical at higher latitudes both because of less intense UV radiation and colder climates leading to less skin exposure. 13 Moreover, cumulative data from comparative anatomy, physiology, and genomics suggest that differences in human skin pigment arose from evolutionary selection pressures involving vitamin D and UVexposure. 14 African ancestry is associated with lower levels; both sunlight and diet result in lower vitamin D levels among persons with stronger African ancestry. 15 These findings raise the possibility that vitamin D disparities could represent a pathway contributing to racial disparity in BP. To date, there have been few studies addressing this question. Judd et al. reported that serum indicators of vitamin D were associated with BP with attenuation of age-related increases in BP among white, but not Black non-hypertensive adults adjusted for sex, body mass index (BMI), and season. 16 Another study of untreated adults suggested that low serum vitamin D levels explained about half of the Black risk (relative to Whites) in hypertension; this study controlled for age, sex, BMI, and physical activity. 17 These findings are limited by limited control for confounding; vitamin D is associated with many additional aspects of health.
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To further evaluate the potential contribution of low serum vitamin D levels to racial differences in BP, we used detailed health information from a current national US sample to control for multiple potential confounders.
METHODS

Participants
We assessed publicly available data from the National Health and Nutrition Examination Survey (NHANES) conducted from [2001] [2002] [2003] [2004] [2005] [2006] . The overall response rate for the NHANES 2001-2006 examined sample was 77.5%. Our sample included nonHispanic Black, and non-Hispanic White participants aged 20 years and older, who participated in the baseline examination (n=10,504) and for whom BP and serum vitamin D levels were available. Of these, 659 lacked information on vitamin D, 597 had no systolic BP reading, and 1131 had neither, for an item response rate of 89% (n= 9,373). We then excluded participants who had a positive urine pregnancy test result or self-reported being pregnant at exam, (n=480) and those with early renal disease (estimated glomerular filtration rate <60 ml/min using the MDMR equation 19 or urine albumin-tocreatinine ratio [UACR] >30 mg/g) (n=1,782) for a total of 7,140 participants in our analytic sample.
Blood Pressure
BP was measured by physicians trained in assessment using mercury sphygmomanometry and appropriately sized arm cuffs. [20] [21] Readings were taken from participants while sitting after five minutes of rest. In determining mean BP, we followed NHANES recommendations. In most instances, the second and third values were averaged. When only two measures were available, we used the second reading to minimize office hypertension. We used systolic BP (SBP) as our outcome because it is more strongly associated with cardiovascular mortality than diastolic BP.
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Vitamin D 22 We grouped vitamin D into quintiles given the potential for non-linear effects.
Race and Ethnicity
We assessed race/ethnicity (Black vs. White) based on selfreport. Because our focus was on the difference in SBP between Blacks and Whites, we excluded Hispanics and those of "Other" race to improve the fit and validity of the regression models we used for making the adjusted comparisons of interest. Notably, Hispanics represent a heterogonous group with variable African ancestry. 24 
Control Variables
To 
Statistical Analyses
Analyses were conducted with SUDAAN (version, 10.01) and Stata (v.10.1, College Station, TX), adjusting for the complex survey design of NHANES to yield appropriate design-based population parameter estimates and standard errors. We examined the Black-White differences in SBP using a series of multiple linear regression analyses. The analyses adjusted for demographics, added, in turn, socioeconomic and social characteristics, health and health care, behavioral risk factors, and biomarkers. For each set of covariates, we compared the BlackWhite differences in SBP without and with adjustment for 25(OH) D. We compared the linear regression coefficient estimates for Blacks from models that excluded and included 25(OH)D using the method of Clogg et al. 28 as a test for the hypothesis that Vitamin D partly accounts for higher Black BP. The percent attenuation was defined as 100 *(
where β is the estimated regression coefficient for Black race, and Model 1 excludes and Model 2 includes 25(OH)D. Because of smaller sample sizes, we trimmed the models for the supplementary analysis. We omitted variables with p values >0.2 and whose omission resulted in less than a 10% change in the race effect on SBP. This resulted in omission of serum cotinine and dietary nutrients. In order to minimize further sample attrition, each variable was added separately and then removed before the next variable was added. This resulted in education and health insurance being removed from the physical activity monitor analysis and poverty, usual source of care and A1C being removed from the cardiovascular fitness analyses.
Sensitivity analyses assessed the contribution of non-linear components of all continuous covariates (by including them as categorical variables or squared terms), examined serum 25(OH) D levels as a continuous variable, and also excluded those taking antihypertensive medications. We conducted an analysis restricted to those with hypertension (systolic >140 and/or diastolic>90). Finally, we examined models including interactions between 25(OH)D and race. We checked all models for outliers and model fit.
RESULTS
Our final sample included 1,984 and 5,156 non-Hispanic Black and non-Hispanic White participants, respectively, ages 20 and older. Following weighting, this corresponds to 12.2% Blacks within the sample. Table 1 compares the characteristics of these groups. Notably, 61% of Blacks compared to only 11% of Whites had 25(OH)D levels in the lowest quintile, whereas only 2% of Black compared to 25% of Whites had levels in the highest quintiles. Visual inspection of SBP and 25(OH)D levels showed normal distribution of these variables and their error terms and no influential outliers. Explained variance (R 2 ) for adjusted the models ranged from 20 to 23%. The additional variance explained by 25(OH)D was similar across SBP. In crude models (no adjustment), participants in the lowest quintile of serum 25(OH)D had SBP that was 5.09 mm Hg higher than those in the highest quintile. In all models, serum 25(OH) D showed statistically significant associations with SBP. In the fully adjusted model, participants in the lowest quintile for 25(OH)D had a mean SBP that was 2.64 mm Hg ( 95% CIs 2.58-2.70) higher than those in the highest quintile. Table 2 shows the adjusted effect of serum 25(OH)D on Black-White differences in BP with sequential controls added. The first column shows the difference in BP before adjustment for vitamin D. The second column shows the effect after 25(OH) D was added to the model and the third column shows the percent reduction in the adjusted Black-White BP difference with corresponding 95% confidence intervals (CI).
The attenuation in the Black-White differences varied from 25% to 28% depending on the control variables included. Before any adjustment, the mean difference in BP between Blacks and Whites was 3.3 mm/Hg. In the final model, 25(OH) D accounted for 26% (95% CI 7-46%) of the residual difference in BP between Blacks and Whites. When participants taking BP medications were excluded, the addition of 25(OH)D reduced the effect of race by 39% (95% CI 14-65%).
Results generally consistent in magnitude with the main analysis were observed in supplementary analyses conducted with age subgroups of the sample. In no instance did controlling for the new measure have an appreciable effect on the Black-White difference in SBP (details available from authors). The addition of 25(OH)D to the model resulted in the race disparity being significantly reduced only in the skin type model (32 %; 95% CI 8-57%), the DXA model (48%; 95% CI 22-74%), and social support model (22%; 95% CI 0.1%-43%). In the remaining supplementary models the effects were not statistically significant, though the direction and effect sizes were generally consistent with the presented analyses.
When we restricted the sample to participants with hypertension (N=1,726) and included all covariates, we observed similar results though larger effects. The lowest quintile was associated with statistically significant 6 mm higher SBP. Notably, adjustment for vitamin D status reduced racial differences in mean SBP from a statistically significant 3.2 mm Hg to a non-statistically significant 0.7 mm Hg. Other sensitivity analyses revealed consistent findings. These included use of 25(OH)D as a continuous variable, substitution of categorical variables or squared terms for continuous variables (details available from authors). There was no significant interaction between race and 25(OH)D.
DISCUSSION
Given the strong association between Black race and low vitamin D levels and growing evidence that suboptimal vitamin D status may be associated with increased BP, we examined the hypothesis that low serum 25(OH)D levels partly explain racial differences in SBP. Our findings support this hypothesis. In the fully adjusted model, differences in levels explained one quarter of the difference. The effect size was consistent across a variety of covariate controls, suggesting a consistent independent effect of vitamin D. When participants taking BP medications were excluded, the effect of 25(OH)D explained 40% of this disparity.
The finding that vitamin D explains a significant portion of the residual difference in BP between Blacks and Whites is consistent with a previous analysis by Scragg et al. from an earlier sample from NHANES III. 17 Judd et al. reported an inverse association between vitamin D and BP among nonhypertensive Whites, but not among Blacks after adjusting for sex, BMI and season. 16 In contrast to those studies, our study included participants with and without hypertension and controlled for multiple confounders including use of objective measures. Regardless of adjustment, lower serum 25(OH)D levels contributed to disparity in SBP. BMI is associated with lower vitamin D levels particularly in whites, 29 possibly due sequestering in adipose tissue, decreased sunlight exposure, and disruption of endocrine feedback loops. 30 For this reason, we used objective measures of body fat based on DXA scanning. Including this measure did not appreciably alter our findings. Similarly, differences in diet, particularly calcium, potassium, and sodium have been suggested as potential explanations for racial disparity in hypertension. 31 Yet, dietary differences in these nutrients based on 24-hour dietary recall did not explain racial differences in BP. Vitamin D proved to be among the most powerful and consistent contributors to Black-White differences in BP. Our findings are consistent with growing evidence that suboptimal vitamin D status is associated with higher BP. 12 While findings from prospective studies regarding the effect of baseline vitamin D on subsequent SBP have been conflicting, [32] [33] [34] discrepant findings may reflect differences in control for confounders and statistical power. Some studies may have been too small to detect an effect of the magnitude we observed. Interventional data are limited. Several small randomized controlled trials of vitamin D supplementation have also yielded conflicting findings. 35 These conflicting findings likely reflect differences in the characteristics of participants, particularly baseline SBP, baseline levels of 25(OH)D, vitamin D doses, and inadequate statistical power. While our study is cross-sectional, it controlled for multiple confounders, was based on a large national sample, and yielded consistent results across different models. The primary limitation of our findings is that our data are crosssectional precluding examination of temporal relationships between vitamin D status and BP. While we controlled for many potential confounders across various domains, it remains possible we omitted important confounders. In addition, cross-sectional analyses may not adequately capture cumulative exposure to risk factors over time or effects during critical developmental periods. This applies to factors such as BMI and diet, as well to vitamin D. In addition, dietary recall likely underestimates the effect of diet; 24-hour dietary sodium recall shows low to moderate correlation with 24-hour sodium excretion. 36, 38 Other limitations include lack of control for season (not publicly available) and diurnal variation (greater among Whites than Blacks). Vitamin D did not fully explain the racial difference in BP in the full sample. It is likely that other factors, beyond Vitamin D, such as psychosocial stress, medication adherence, and discrimination also contribute to this disparity. 4, [38] [39] [40] While we were unable to adjust for these factors, we observed similar results following adjustment for social support, a well recognized buffer to psychosocial stress. We observed stronger effects when we excluded participants taking BP medications, suggesting that adherence is unlikely a major confounder. Similarly, we observed stronger effects when we confined the sample to those with hypertension suggesting effects extend to those with clinically relevant SBP. The association between discrimination and skin color represents a potential confounder. Persons with darker skin (independent of race) have lower educational attainment and experience greater discrimination in the job market. [40] [41] [42] However, the relationship between objectively measured skin tone and BP is complex and appears to differ by income. [44] [45] Our measure of skin type (i.e. Fitzpatrick score) was relatively crude. It was not significantly associated with SBP, and it attenuated, but did not eliminate the effect of 25(OH)D on the race difference. In summary, our findings are most consistent with the hypothesis that vitamin D represents one piece of the complex puzzle of race and BP. Further study using more refined measures of skin color is needed to tease apart the complex relationship between skin color, psychosocial stress, vitamin D status, and BP. In contrast to previous studies that excluded persons diagnosed with hypertension 16, 17 we included all non-pregnant adults without renal disease with a wider range of SBP. A meta-analysis of 61 prospective studies showed that the proportional difference in the risk vascular-related death associated with a given absolute difference in usual BP is about the same down to at least 115 mm Hg. 21 Hypertension is the most important proximal determinant of disparities in cardiovascular disease. 46 At a population level, seemingly modest Black-White differences in BP represent thousands of excess Black deaths annually from heart disease and stroke. 47 Thus, interventions that appreciably reduce this gap could have a population-wide impact on racial disparities in these outcomes. Our findings add to the growing body of evidence that low levels of vitamin D among Blacks contribute to cardiovascular disparities. Suboptimal vitamin D has been linked to conditions more prevalent among Blacks including diabetic nephropathy, 48 peripheral vascular disease, 49 kidney disease progressing to renal failure, 50 and cardiovascular mortality. 51 Blacks also have higher rates of endothelial dysfunction and small vessel disease than whites. [52] [53] Emerging data suggest that low vitamin D levels are associated with endothelial dysfunction and that correction alleviates this dysfunction. Together these findings point towards vitamin D deficiency as a potential contributor to higher rates of vascular dysfunction, including hypertension among Blacks living in the United States. These emerging findings regarding the role of vitamin D in cardiovascular disparities have important implications for addressing racial disparities in cardiovascular morbidity and mortality using a simple downstream intervention. 60 They suggest the possibility of partially mitigating these disparities through oral supplementation with sufficient doses. 61 Thus, there is an urgent need for randomized controlled trials conducted across a range of ages and using various outcomes to rigorously test the hypothesis that vitamin D represents an important contributor to racial disparities in hypertension and cardiovascular conditions. 
